Nihal Yıldız

The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study

A. Serdaroğlu, A. Cansu, P. Gencpinar, 2022, Epilepsy Research.

An investigation of the effects of chronic zonisamide, sultiam, lacosamide, clobazam, and rufinamide anti‐seizure medications on foliculogenesis in ovarian tissue in prepubertal non‐epileptic rats

A. Cansu, U. Yazar, E. Arslan, 2022, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience.

Primary intestinal lymphangiectasia co-existing with rotavirus infection. Who pulled the trigger for protein loss?

E. Sevinç, E. Doğan, Nihal Yıldız, 2018, Annals of Gastroenterology and the Digestive System.

Evaluation of Long-Term Effects of Levetiracetam Monotherapy on Hematological and Liver Function Parameters in Children With Idiopathic Epilepsy

A. Cansu, H. Yaman, S. Karahan, 2022, Turkish Journal of Pediatric Disease.

SLC26A3 mutation in Turkish neonate and her sibling with congenital chloride diarrhea

E. Sevinç, E. Doğan, Nihal Yıldız, 2018, Turk pediatri arsivi.

Shared Biological Pathways and Processes in Patients with Intellectual Disability: A Multicenter Study

S. Yılmaz, A. Gezdirici, Y. Karal, 2022, Neuropediatrics.

Pseudo-Petit Mal Discharge: A Marker of Favorable Prognosis in Febrile Seizure

A. Cansu, B. Dilber, T. Kamaşak, 2022, Archives of Epilepsy.

An Investigation of Changing Attitudes and Behaviors and Problematic Internet Use in Children Aged 8 to 17 Years During the COVID-19 Pandemic

M. Topbaş, A. Cansu, T. Kamaşak, 2021, Clinical pediatrics.